Innocoll Holdings, a pharmaceutical and medical device company, named Richard Fante as its new CEO.

Fante previously served in leadership roles at AstraZeneca years, including as president of its U.S. division and CEO of North America.

Fante joined Innocoll in 2015 and served as CCO and head of business development during the company’s acquisition by Gurnet Point.He succeeds Anthony Zook as CEO.